Biden Administration Faces Opposition over Proposed Menthol Ban

Regulations by 2FIRSTS.ai
Nov.20.2023
Biden Administration Faces Opposition over Proposed Menthol Ban
Biden administration faces bipartisan opposition as it considers a ban on menthol cigarettes, with concerns about economic impact and racial disparities.

According to a report in The Washington Observer on November 19, the Biden administration is facing opposition from both parties over its decision on the proposed ban on menthol cigarettes. Critics argue that this move will have a negative impact on the economy and disproportionately affect communities of color.

 

The decision on whether to implement a ban on menthol cigarettes and flavored cigars is expected to be released as early as this week, following the first proposal made by the Food and Drug Administration (FDA) in spring 2021.

 

Legislators and advocacy groups have criticized the proposal, arguing that it would lead to an increase in illegal sales and inconsistent enforcement.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Greek man injured in e-cigarette explosion, requires dental surgery, experts urge focus on e-cigarette safety
Greek man injured in e-cigarette explosion, requires dental surgery, experts urge focus on e-cigarette safety
A man in Crete suffers dental injuries after e-cigarette explosion, raising concerns over safety. Expert calls for vigilance.
Sep.16 by 2FIRSTS.ai
A former Singapore Health and Science Agency (HSSA) authorized enforcement officer has been charged with leaking e-cigarette enforcement intelligence in a bribery case
A former Singapore Health and Science Agency (HSSA) authorized enforcement officer has been charged with leaking e-cigarette enforcement intelligence in a bribery case
A former e-cigarette enforcement chief in Singapore has been charged with accepting a S$8,000 (US$6,200) bribe after repeatedly providing intelligence to a man involved in an upcoming Health Sciences Authority (HSA) e-cigarette crackdown in 2024.
Sep.05 by 2FIRSTS.ai
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
The U.S. FDA will review Philip Morris International’s renewal application for five IQOS products' modified risk status at an October 7 TPSAC meeting, evaluating whether they still meet the required standards.
Jul.30 by 2FIRSTS.ai
Belgium to Tighten Tobacco Controls in 2027: Vaping Banned on Café & Restaurant Terraces; Shisha Bars to Close
Belgium to Tighten Tobacco Controls in 2027: Vaping Banned on Café & Restaurant Terraces; Shisha Bars to Close
The Belgian government has announced a new round of tobacco-control measures: starting January 1, 2027, smoking traditional tobacco and using e-cigarettes will be banned on café and restaurant terraces, all designated indoor smoking rooms will be abolished, and shisha bars will be closed. The ban applies to both customers and operators; terraces must display no-smoking signage, and even placing ashtrays on tables will be subject to penalties.
Sep.16 by 2FIRSTS.ai
Products | Bluetooth Headphone Vapes Spark Discussion as Airmez Launches New 120,000-Puff Product in the U.S.
Products | Bluetooth Headphone Vapes Spark Discussion as Airmez Launches New 120,000-Puff Product in the U.S.
E-cigarette brand Airmez recently launched two new high-puff-count products in the U.S. market, offering up to 120,000 puffs. The brand previously gained market attention for a product with a built-in Bluetooth headset. This article will outline the specifications of Airmez's two new products and review the social media buzz and user feedback on its built-in headset product.
Aug.22 by 2FIRSTS.ai
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans
Health professionals worldwide are urging a shift from abstinence-only tobacco policies toward evidence-based harm reduction. Despite bans, smoking remains prevalent in countries like India, while prohibition fuels black markets in Europe and misinformation among doctors in the U.S. Many argue that regulated alternatives could save lives where cessation fails.
Sep.09